Navigation Links
Sun Pharma Commences All Cash Tender Offer to Purchase Taro Ordinary Shares for USD 7.75 Per Share

MUMBAI, India, June 30 /PRNewswire-FirstCall/ -- Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) today announced that Alkaloida Chemical Company Exclusive Group Ltd. (Alkaloida), a subsidiary of Sun Pharma, has commenced a tender offer for all outstanding Ordinary Shares of Taro Pharmaceutical Industries Ltd. (Taro) for USD 7.75 per share in cash.

On May 18, 2007, Taro and Sun Pharma's subsidiaries entered into a Merger Agreement whereby Sun Pharma's subsidiary would acquire Taro, which the Taro Board of Directors unanimously approved. In the event the merger was not consummated, Taro's controlling shareholders led by Taro's Chairman, Barrie Levitt, granted Sun Pharma an option to acquire all their shares, including all of the Founders' Shares of Taro. On May 28, 2008, Taro improperly terminated the Merger Agreement, an action which Sun has challenged in the Supreme Court of the State of New York.

On June 25, 2008, Alkaloida exercised its Option under its Option Agreement to acquire all the shares held by the controlling shareholders of Taro. As required by the Option Agreement, Alkaloida has commenced a Tender Offer for all Ordinary Shares. The Option Agreement required that the Tender Offer be at USD 7.75 per share.

The tender offer is scheduled to expire at 12:00 midnight, New York City time, on Monday, July 28, 2008, unless the tender offer is extended.

The tender offer is not conditioned on the availability of financing or the approval of the Board of Directors of Taro.

The complete terms and conditions will be set out in the Offer to Purchase, which will be filed with the U.S. Securities and Exchange Commission today, June 30, 2008. Taro shareholders may obtain copies of all of the offering documents, including the Offer to Purchase, free of charge at the SEC's website ( or by directing a request to MacKenzie Partners, Inc., the Information Agent for the offer, at 105 Madison Avenue, New York, New York 10016, (212) 929-5500 (Call Collect) or Call Toll-Free (800) 322-2885, Email:

Greenhill & Co., LLC is acting as the Dealer Manager for the tender offer and MacKenzie is acting as the Information Agent for the tender offer.

About Sun Pharmaceutical Industries Ltd.

Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, U.S. and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, and orthopedics. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at


Uday Baldota

Tel +91 22 6645 5645, Xtn 605

Tel Direct +91 22 66455605

Mobile +91 98670 10529

E mail

Mira Desai

Tel +91 22 6645 5645, Xtn 606

Tel Direct +91 22 66455606

Mobile +91 98219 23797

E mail

Brunswick Group for Sun Pharma MacKenzie Partners

Nina Devlin / Erin Becker Robert Marese

+1 212 333 3810 +1 212 929 5500

Arad Communications for Sun Pharma Greenhill

Gali Dahan Ashish Contractor

+972 3 7693320 +1 212 389 1537

SOURCE Sun Pharmaceutical Industries Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services
2. Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution
3. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
4. MDS Pharma Services Names Dr. Lori McDonald to Executive Leadership Team
5. Avalon Pharmaceuticals names lead development candidate in beta-catenin inhibitor program
6. KV Pharmaceutical Company Completes Fiscal 2008 Filings With Securities and Exchange Commission
7. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
8. Catalyst Pharmaceutical Partners, Inc. Set to Join Russell Microcap(R) Index
9. Microsoft Announces Winners of the 2008 Pharmaceutical and Life Sciences Innovation Awards
10. CEVA Logistics Awarded Best 3PL Provider for Pharmaceutical, Chemical, HazMat and Fresh Food Supply Chains
11. NACDS Praises House Legislation to Delay Medicaid Cuts, Aid Pharmacies in Treating Patients
Post Your Comments:
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation ... the 2015 IBC National Meeting in Rosemont, IL on October 4th. ... and standards of excellence that customers have come to expect from members of IBC’s ...
(Date:10/12/2015)... ... ... Kevin Costello, winner of the “Check-In and Win a Vacation to Hawaii” Facebook contest at ... Hawaii. , “I didn’t believe I could win a free vacation simply by checking in ... to the gym and invest in my own health – and now I’m going to ...
(Date:10/12/2015)... Woodinville, WA (PRWEB) , ... October 12, 2015 , ... ... , a premier supplier of spa and skin care equipment, will be displaying custom ... October 19-21, 2015. , With many high-end resorts and spas as customers, SpaEquip is ...
(Date:10/12/2015)... ... October 12, 2015 , ... ... of hypnosis by individuals who lack professional education and clinical training in a ... public for a variety of purposes such as: losing weight, managing pain, or ...
(Date:10/12/2015)... ... October 12, 2015 , ... American Family Care (AFC), the ... footprint by opening its 151st medical center. Located at 606A Boll Weevil Circle in ... to continue fulfilling our mission of making quality health care accessible and economical with ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... , October 12, 2015 ... key insights on the global vital signs monitoring devices market ... Global Industry Analysis and Opportunity Assessment 2015-2025." The global vital ... healthy CAGR of 9.5% and 9.2% in terms of value ... regarding which FMI offers major insights in detail in this ...
(Date:10/12/2015)... , Oct. 12, 2015 Beginning October ... Codes. Therapy Partner, the fastest growing practice management system ... technology that easily converts all patient diagnostic codes from ... --> --> Therapy ... for all mental health practitioners to easily understand the ...
(Date:10/12/2015)... 12, 2015 Indivior PLC (LON: INDV) today announced ... Delaware granted the Company,s motion to amend ... Drug Application (ANDA) No. 205299 to market a generic equivalent ... Sublingual Film (CIII) in the United States ... August 2013, Indivior has received Paragraph IV certifications from six ...
Breaking Medicine Technology: